← All indications
Dyspareunia
Recurrent genital pain occurring during, before, or after SEXUAL INTERCOURSE in either the male or the female.
Drugs by status
Approved for this indication (4)
Phase 4 trials (7)
Phase 3 trials (4)
Phase 2 trials (2)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (15)
- Harvard University
- University of Washington
- Kaiser Permanente
- New York University
- Oregon Health and Science University
- San Diego Sexual Medicine
- University of Athens
- Group Health Cooperative
- University of California, San Diego
- University of Cincinnati
- University of Minnesota
- Patty Brisben Foundation For Women's Sexual Health
- EvergreenHealth
- The Cleveland Clinic
- GTO Pharmaceutical, LLC
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (1)